According to my sources, the SEC/DOJ "investigation" of @ElonMusk is timed to thwart his bid for @Twitter. Normally, in the absence of a better offer, Twitter's board is effectively obligated by its fiduciary duty to shareholders to accept Musk's offer. If true, it's scandalous.
@elonmusk@Twitter (By "if true" I mean, if true that the investigation is an effort to thwart the acquisition.)
Elon has several options if the board uses the excuse of the SEC/DOJ investigation to reject his offer. For example, he can attempt to go directly to the shareholders (which, again, works in the absence of a better offer). Not sure whether he is willing to, though.
Put simply: in a normal situation, if @ElonMusk is willing put in the effort to acquire @Twitter without the board's consent, and no better offer emerges, he is likely to win. Questions are (1) how does the SEC/DOJ affect this? (2) is Elon willing to put in the effort?
I've created confusion by using the word "fiduciary" above, which many have interpreted to mean that I think Twitter is legally required to accept Elon's offer. That's not the case. Twitter's board can reject the offer, but shareholders would likely side with Elon in a vote.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This @bgmasters campaign ad pretty much crystallizes @FREOPP scholars' work on the rising cost of living: housing, healthcare, education are the biggest drivers.
Dems have announced an agreement on drug pricing reform for their multi-trillion dollar reconciliation package. The pharma lobby will holler that "innovation will grind to a halt and we're all gonna die." Here's a massive new @FREOPP study on that topic. freopp.org/high-drug-pric…
@FREOPP In the new study, we analyzed from several angles the question: if Congress limits the power of drug monopolies to raise prices whenever they want, does pharmaceutical innovation suffer? The short answer is no. High up front R&D costs stall innovation, not slightly lower prices.
@FREOPP FREOPP research fellow @GreggGirvan reviewed 1,589 clinical trials, 410 FDA drug approvals, & 10 years of biopharmaceutical financial data. Here's what we found. 1) Drugmakers are investing in R&D where R&D costs are low: rare diseases, which require smaller clinical trials.
“CBDC” may be an obscure acronym to most—it stands for “central bank digital currency”—but it is the single biggest threat to Americans’ personal and economic freedom being seriously considered by the U.S. government. My latest in @NRO: nationalreview.com/2021/10/bidens…
Biden’s nominee to run the Office of the Comptroller of the Currency, Saule Omarova, understands this well. In a 2020 paper, she writes about how CBDCs enable the Fed to see all of your transactions, and add and subtract from your bank accounts at will. papers.ssrn.com/sol3/papers.cf…
By placing the entirety of Americans’ financial and economic activity in a federal database, a CBDC would make that data available to pretty much any skilled hacker around the world, making low- and middle-income Americans vulnerable to scams and theft. nationalreview.com/2021/10/bidens…
Anti-vaxxers claim that COVID vaccines are "experimental." But there's more data vouching for the BioNTech/Pfizer vaccine's safety than there has been for any other vaccine approved by the FDA: wsj.com/articles/the-f…
I'm seeing a lot of misinformation in my timeline related to the reporting of adverse events after receiving a COVID vaccine. Here is the link to the CDC's compilation of reported adverse events. cdc.gov/coronavirus/20…
The highlights: Out of 357 million administered doses of COVID-19 vaccines, VAERS has received 6,789 reports of death from any cause (i.e., not necessarily the vaccine): a rate of 0.0019%. Other side effects were also extremely rare.
$143 billion in improper Medicaid payments over two years is an incredibly high number, even for Washington, representing >18% of all Medicaid spending over that period.
States have no incentive to fight Medicaid waste, because the dollars go to hospitals and businesses in their state, mostly funded by taxpayers in other states.
The joint federal-state structure of Medicaid has been a disaster from the beginning, which is why the Fair Care Act would transition able-bodied Medicaid recipients into tax credits for individually purchased insurance funded purely at the federal level. freopp.org/the-fair-care-…
An unhinged @WSJOpinion op-ed by Steve Hanke and Manuel Hinds recently compared @nayibbukele's El Salvador #Bitcoin Law to laws of the Soviet Union and Nazi Germany. I responded in today's Wall Street Journal letters section. wsj.com/articles/bitco…
I get that ideological libertarians loathe mandates of any kind, and that some in that school strongly oppose requiring merchants to accept bitcoin. I see it differently, because the utility of money is a function of the size of its network.
The reason why big internet companies have become monopolies is because of the scale of their user networks. Large user networks are hard to build. Monetary networks are similarly hard to build. Article 7 of El Salvador's #LeyBitcoin creates a 2nd monetary network in the country.